# Adjuvant Radiation for High Risk Bladder Cancer

> **NCT01954173** · NA · TERMINATED · sponsor: **Emory University** · enrollment: 19 (actual)

## Conditions studied

- Bladder Cancer
- Squamous Cell Carcinoma of the Bladder
- Stage III Bladder Cancer
- Stage IV Bladder Cancer
- Transitional Cell Carcinoma of the Bladder

## Interventions

- **RADIATION:** 3D conformal radiation therapy

## Key facts

- **NCT ID:** NCT01954173
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-07-22
- **Primary completion:** 2021-09-20
- **Final completion:** 2021-09-20
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2022-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01954173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01954173, "Adjuvant Radiation for High Risk Bladder Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01954173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*